Miller, J., Campbell, J., Blum, A., Reddell, P., Gordon, V., Schmidt, P., & Lowden, S. (2019). Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors. Front Vet Sci.
Styl cytowania ChicagoMiller, Jane, Justine Campbell, Andrew Blum, Paul Reddell, Victoria Gordon, Peter Schmidt, i Stewart Lowden. "Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors." Front Vet Sci 2019.
Styl cytowania MLAMiller, Jane, et al. "Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors." Front Vet Sci 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..